OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

Company number: 04480121 Charity Number: 1093808

British Society of Echocardiography

Report and financial statements For the year ended 31 March 2021

British Society of Echocardiography

Trustees’ Annual Report for the Year Ended 31 March 2021

Legal status

The charity is an incorporated charity governed by its Memorandum and Articles. There are no restrictions in the governing document on the operation of the charity or on its investment powers, other than those imposed by general charity law. The full name of the charity is the British Society of Echocardiography; the Society was incorporated as a company limited by guarantee on 8th July 2002 under the Companies Act 1985 and registered as a charity on 13[th] September 2002.

Charity Registration number: 1093808

Registered Company Number: 4480121

Registered Office: Unit 204, The Print Rooms, 164-180 Union Street, London, SE1 0LH

The members of the Board of Trustees of the Charity and Directors of the Company at the date the report and accounts were approved: -

Dr D Augustine Ms S Bennett Dr C Colebourn Ms W Gamlin Dr S Mushemi-Blake Ms C Oxley Mr K Pearce Mr S Robinson Ms J Skipper Prof M Stout Ms K Victor

Chief Executive Officer

Ms J Sopala

Independent Examiner

Caroline Sharp FCA, DChA. London

Bankers

Bank of Scotland. St James's Gate, 14-16 Cockspur Street, London, SW1Y 5BL NatWest. 47 Market Street, Lichfield, Staffs, WS13 6YB

Advisors

Wilson’s Solicitors LLP, Alexandra House , St John’s Street, Salisbury, SP1 2SB Charles Russell Speechlys LLP, 5 Fleet Place, London, EC4M 7RD.

Investment Managers

Chase De Vere, 8 Exchange Way, Salford Quays, Manchester M5 5EJ

1

British Society of Echocardiography Trustees’ Annual Report for the Year Ended 31 March 2021

The Trustees present their report and the financial statements for the year ended 31st March 2021.

Reference and administrative information set out on page 1 forms part of this report. The financial statements comply with current statutory requirements, the memorandum and articles of association and the Statement of Recommended Practice - Accounting and Reporting by Charities: SORP applicable to charities preparing their accounts in accordance with FRS 102.

Introduction

The Society was originally formed in 1991 as an unincorporated body and in October 2001 it was formally agreed that, subject to approval by the Charity Commission, the Society would be absorbed into a newly formed incorporated body. This process was formerly concluded by the October 2002 Annual General meeting and the assets and management of the old charity were formally transferred to the company on 1st November 2002.

The Objects of the Charity and How it is Attempting to Achieve the Objectives

The charity is constituted as a company limited by guarantee and is therefore governed by a memorandum and articles of association. The directors of the company are also trustees of the charity.

The memorandum of association states that the charity's objects are: -

(1) The protection and preservation of health and the effective relief of sickness by:

(2) To advance, promote and carry on study and research into Echocardiography and to disseminate the useful results of any research.

The charity's objects and principal activities continue to be as stated above.

Objectives achieved in the period, a review of activities and significant changes including development and plans for the future

The beginning of the financial period reported on here coincided with the first surge in COVID 19 cases and initial lockdown in the UK. The Trustees would like to take this opportunity to recognise the incredible contribution our members made to maintaining public health and safety under extraordinary circumstances. BSE members played a pivotal role in the fight against the pandemic and in maintaining, then re-establishing with urgency, echo services for all.

We would also like to acknowledge the sterling work of Council, the BSE Committees and our officebased team in prioritising member safety, adapting quickly and for ensuring we could continue to run our core services despite the uncertainty and additional challenges presented by the pandemic.

The Board of Trustees are pleased with the performance of the charity during the period and the financial position as of 31st March 2021. The Society has built on its strategy of stabilisation, initiated in the financial year 2019/20, and despite the impact of the COVID 19 pandemic, performed well in 2020/21. They consider the charity to be in a strong position to continue its activities during the coming year, and that the charity's assets are adequate to fulfil its obligations.

2

British Society of Echocardiography Trustees’ Annual Report for the Year Ended 31 March 2021

A budgeted deficit was set for the year with expectations being that this would be a financially difficult period. However, we have ended the year with a surplus. It was wise to budget prudently during this period, given the immense uncertainty, and this has returned the Society to a stable financial footing. The surplus can now be used over the coming years to support our members, through a bursary programme and support of other membership benefits.

Membership at the end of the year reached 4,158. The breakdown of membership according to profession highlights two thirds of our members are Physiologists and the remaining one third are Physicians/Cardiologists, Anaesthetists, and others (e.g. GPs and junior doctors). Membership fees for 2020/21 were priced at £100 for Standard Membership, £70 for Pre-Accreditation members.

A police investigation into the misappropriation of funds (first reported in the 2018/19 Trustees Annual Report) has resulted in an individual being charged in relation to this matter. The Society has put in place robust financial processes and has initiated a Governance Review to ensure it is protected from such actions in the future.

Advancement of Education . Despite the enormous challenge of COVID-19 measures which prevented face-to-face meetings the Society delivered its objectives relating to education, training and promotion of best practice in a number of ways within the last year by providing and facilitating webinars, virtual events and online learning resources; issuing guidelines and disseminating guidance via the website and educational posters. The aim remains to deliver training and education to as many members as possible.

The Society's Annual Conference BSEcho 2020 was held virtually between the 5[th] and 10[th] October and surpassed all expectations. Despite the exceptionally short timeframe to move from a face-toface event to a virtual one, it proved to be our most successful annual conference to date for educational content provided and the number of delegates attending. Attendance was over 1,500 people, compared to 1,082 in 2019, and the Education Committee again delivered an outstanding array of sessions, talks, speakers and abstract presentations that covered all aspects of clinical echocardiography, research, education and service provision. The quality of the programme is testament to the fact that 93% of delegates surveyed would recommend attending to their colleagues. Continued support from our industry partners at the conference is appreciated, and the income generated from the virtual exhibition supports the Society in its other activities.

Although COVID-19 measures introduced many restrictions on how we were able to deliver events, there have been positive outcomes to the alternate ways we have continued to provide education, the Exam Preparation course being a prime example. As the face-to-face format was not going to be possible for 2020/21, we have created an entirely digital course on a dedicated e-learning platform, which includes clinical talks followed by multiple choice questions in the style of the BSE TTE accreditation exam. The Exam Prep course runs twice a year (Sept and March) with the content being available for delegates to review for a month. Attendance has been excellent (243 candidates in this financial year, compared to 69 last year) and feedback from the courses in September 2020 and March 2021 have been instrumental in enabling us to make the alterations to ensure the course delivers its purpose of preparing candidates for the TTE accreditation exam.

Advanced Imaging 2020 was sadly cancelled as a result of the pandemic, but replaced in part by our COVID-19 webinar on the 13[th] May 2020. This online webinar in conjunction with the Royal Society of Medicine (RSM), entitled ‘Echo in the COVID-19 era: planning for the new normal’, focussed on the echocardiographic findings in patients with COVID-19 and guidance for how to provide an echocardiography service during the COVID-19 pandemic. This webinar attracted over 1,000 delegates and is the highest attendance of any RSM sub-speciality webinar. This compared with 385 delegates for the face-to-face meeting in the previous year. Feedback for the meeting was

3

British Society of Echocardiography Trustees’ Annual Report for the Year Ended 31 March 2021

outstanding with 99.9% of delegates finding the webinar recommendable to colleagues. We collaborated again with the RSM to deliver our Endocarditis webinar on the 10[th] February 2021. This online webinar discussed a practical approach to TTE, PET-CT and TOE assessment of endocarditis. The webinar attracted over 300 delegates. There was excellent feedback including 99.1% of delegates finding the webinar recommendable to colleagues.

Continuing the switch to digital format saw the BSE + ICE conference become a two-day event in early March (5[th] and 6[th] March 2021). This conference has always been extremely popular when held in Ireland and proved even more so as a digital event with over 500 delegates attending the Friday afternoon and Saturday morning meeting (131 delegates in March 2020). Although technical difficulties with the host site caused minor disruption to the programme, feedback was excellent and the event was a huge success.

Regional meetings continue to play a vital role in the delivery of local education, covering important regional topics and providing the opportunity for learning and re-accreditation points. Although we were unable to run all of the regional events we had planned for over the past year, we were able to run 2 regional online webinars. These were hosted at the Prince of Wales Hospital (November 2020) and University Hospitals of North Midlands (March 2021). Thank you to all of those who helped to deliver these excellent educational events locally.

In December 2020 we launched our pulmonary hypertension distance learning module (DLM). Whilst DLMs usually attract a nominal fee, this important educational tool for our members was provided free of charge thanks to a generous grant from the British Heart Foundation. Our thanks also to Janssen Ireland who provided funding to allow non-members to access the resource.

During the period of this report the following guidelines were published:

In addition to these new guidelines, a poster highlighting the BSE Normal Reference Intervals was published and delivered to UK NHS Trusts.

The rapidly evolving Covid emergency necessitated frequent communications with our members. From guidance on PPE to a secure community facilitating private discussion on protocols and operating procedures, the BSE’s website provided up-to-the minute support for our members.

We were proud that, throughout this period, ECHO Journal continued to arrive in inboxes and on doorsteps quarterly. The ECHO Journal is only possible due to the generous inputs from members who provide examples of interesting cases, different ways of working, and quality and service initiatives. Thank you to those of you who submitted last year and contributed significantly to the knowledge base. In addition to member inputs, the Communications subcommittee commissioned articles from experts and leaders in the field of echocardiography.

As the agreement with the previous publisher of Echo Research and Practice came to an end, the Editors and a BSE ERP steering group reviewed the aims of the journal, including feedback from members and initiated a process to identify a new publisher aligned with the BSE’s goals. Springer

4

British Society of Echocardiography Trustees’ Annual Report for the Year Ended 31 March 2021

Nature have been appointed as the new ERP publishing house, with ERP expected to reopen for submissions later in 2021.

We continued to see more and more growth in relation to our social media presence. For this period we had 6,300 followers on Facebook and over 5,900 followers on Twitter. That’s over 1,700 new followers compared to last year. Even more impressive, our Twitter impressions cracked the million mark (1.3 million to be exact)! Our social media platforms continue to provide a vital source of engagement with and feedback from our members.

For the purpose of the annual returns, all educational meetings and courses are categorised together and over the year, total income was £300k (2020: £380k) with direct expenditure of £139k (2020: £240k) giving a surplus of £161k (2020: £140k), before allocation of £141k (2020: £173k) staff salaries, support and governance costs.

Promoting High Standards of Professional Competence . The Society seeks to promote high standards of professional competence through personal accreditation and revalidation. Despite the impact of the pandemic, we have continued to provide our written theory exam in partnership with Pearson Vue for all specialities. Our candidates were prioritised as key workers, enabling our theory examinations to continue in line with Government guidance on social distancing and following COVID-19 safely regulations.

This process was significantly helped by the introduction of remote theory exams, which we were able to introduce in time for the October written exams. Thanks to Pearson Vue for recognising our candidates as a priority during this period. A total of 482 candidates sat their written exams over this time in October 2020 and March 2021. This compared with 590 candidates in 2019/20 when we ran 3 written exams over the course of the year.

Recognition of our candidates as key workers by the Department of Health ensured BSE practical assessments were classified as essential. This meant that our practical assessment days could go ahead in a Covid secure manner and allowed us to open up a practical assessment in August 2020 for the benefit of those candidates registered for the cancelled March and June sittings. We incorporated an advance questionnaire checklist for candidates and assessors 48 hours before the assessment day. The checklist, along with a temperature check, were also undertaken on arrival of the assessment day. If there were concerns around the candidates or assessors' health, our protocol meant that the person in question would not be allowed into the assessment venue.

As an additional safety measure, we have incorporated simulators into our practical scanning station in place of live models. We are very grateful for the support from HeartWorks for this. Although this obviously does not mimic a real-life patient, the overall feedback from candidates has been positive. Candidates were not penalised for not having used a simulator before.

Despite this, there were still challenges for candidates based in Scotland, Wales, Northern Ireland and Ireland. As a result, we piloted a virtual practical assessment day for these candidates. This paved the way to our first fully virtually practical assessment held in January 2021. Despite some inevitable technical glitches, these were a success and enabled candidates to progress through accreditation.

Logbook marking for the entirety of this period has been undertaken before the assessment day and marked by a dedicated group of assessors. To ensure consistency, all marks have been reviewed and agreed by the logbook national station leads Deepa Suresh, Ivo Andrade and Co-Chair Sadie Bennett. This has meant candidates have had to submit the logbook approximately 8 weeks in advance; however, it has allowed for a much smoother and socially distanced assessment day .

5

British Society of Echocardiography Trustees’ Annual Report for the Year Ended 31 March 2021

This year 219 (2020: 361) candidates were assessed and 178 (2020: 238) were accredited.

To support our members and remove undue pressure during this period, a 12-month automatic extension policy was introduced for all members who were due re-accreditation in 2020/2021. Despite this many members have chosen to reaccredit in the usual way. In total, 152 re-accredited in June 2020 and 142 in December 2020. This compares to a total of 381 reaccreditations in 2020. We have received 175 extension requests for this period, of which 147 are Covid related.

The income from accreditation during the year was £164k (2020: £210k) with direct costs of £136k (2020: £200k) resulting in a surplus of £28k (2020: surplus of £10k), before allocation of £77k (2020: £97k) support and governance costs. The decrease in annual income reflects two written examinations being held during the year compared to three in 2019/20.

This year we have reviewed our endorsement process and continue with current guidelines and process. Applications for endorsements are evaluated by a member of the accreditation team with appropriate expertise in the area of the proposed course. The endorsement provides assurance that the course aligns with BSE accreditation and re-accreditation processes and allows course directors to utilise the BSE logo for advertisement. With few courses being delivered, it is not surprising that only two course endorsement applications have been received. Although one was a repeat course and the other was a new event, both were successful.

We have manged to continue some Departmental Accreditation activity during this period. Two new departments achieved accreditation. Congratulations to the teams at Antrim Hospital, Northern Ireland and North Bristol NHS Trust. Three sites successfully reaccredited. Congratulations to the teams at Liverpool Heart & Chest Hospital, Kettering General Hospital and Royal Berkshire Hospital.

We have temporarily moved to virtual departmental accreditation visits due to the pandemic. There have been two successfully completed virtual visits so far with good feedback from assessors and departments on the process and plans to further improve process going forwards. We plan to return to face-to-face visits or possibly hybrid visits as soon as practicable. The virtual process may also be used at 5yr reaccreditation where a site visit is not normally required.

We would like to give special thanks to our Patient Representative from the Wavelength group, who has now undertaken 2 virtual visits with really positive feedback from departments and from visiting teams. There are plans to develop further patient representative involvement with departmental accreditation going forwards.

The Echo Quality Framework (EQF) area of the website was launched in December 20. Within a month of launching there were ten expressions of interest. We are currently reviewing evidence for the first departments to apply.

There are 2 functions of the EQF:

  1. Stand-alone application for “Echo Quality Accreditation” where departments apply for peerreview of EQF evidence (by Clinical Standards Committee members).

  2. For departments holding BSE departmental accreditation, ongoing participation in EQF is expected and evidence will be reviewed by visiting team at accreditation/reaccreditation.

We have not received any Emergency Echo Departmental Accreditation applications to date, we assume as a direct result of the impact of COVID. However, with the recent drive from Government for all Trusts to provide level 1 echo 24/7, we anticipate future interest. This is now available as a stand-alone module (N.B. This still requires some interaction with level 2 accredited members of wider echo team).

6

British Society of Echocardiography Trustees’ Annual Report for the Year Ended 31 March 2021

In November 2020 we opened for applications to the Resilience in Leadership Course, the first pillar of our BSE Leadership Academy. We had been granted funding to provide the programme to six echo department leads, but having received over 30 applications, the pilot course was offered to 11 members. The initial cohort, comprising of both Physiologists and Cardiologists, came from a wide geographical spread across the UK. They undertook an intensive course of 1-2 hour individual and group coaching and learning sessions (55 sessions in total, over a 4 month period) facilitated by our partners at the Kairos Project (thekairosproject.org).

The purpose of the programme was to look after the wellbeing and resilience of echo leaders, to provide them with tools and skills to build resilient teams and to generate new ways of navigating difficult situations.

Feedback suggests that participants valued the process greatly, although for some it was a challenge to secure protected time. Whilst this form of intensive investment in leaders is common in both the private and charity sectors it is less available. This course was made possible by a benevolent funder who was willing to invest in NHS staff. The BSE has been fortunate to be able to link these patrons with our members and given the resounding success of this initial pilot we have been able to secure further funding (matching that already put forwards by the BSE) to allow more of our members the opportunity to go through this process.

To Advance, Promote and Carry on Study into Echocardiography. The BSE has an active Research and Audit subcommittee which sits within the Education Committee. In September 2020 we launched the BSE national review of stress echocardiography practice (BSE-NSTEP). This is a UK registry data on stress echocardiography practice and is a partnership with the EVAREST study. This presents a valuable opportunity to review how stress echocardiography is being delivered in real world clinical practice in the UK and allows us to build a national picture of our stress echo use. Information on all forms of stress echo will be captured including assessments for ischaemia, valve disease and viability. From the data it will be possible to analyse protocols; outcomes and cost effectiveness of stress echocardiography within the NHS to promote best practice. At the time of writing this (June 2021), the registry had recruited over 1,400 patients.

The Organisational Structure and How Decisions Are Made

The Society has a full-time Chief Executive Officer who works with a team of 5 full time and 1 part time staff members, who are responsible for delivering all administrative, accreditation, financial, marketing and educational activities. We would like to thank the team for their exceptional work during this period. At short notice they have pivoted the Society’s core activities to digitally led offerings to ensure we could continue delivering for our members. We continue to grow our team to support the Society’s work with members as required.

The BSE is governed by a board of Trustees. The Board is supported in its decision making by a Council which consists of elected members, the Trustees, and co-opted members as well as representatives of professional groups and organisations with an interest in echo.

The Board of Trustees meets at least 4 times each year. The work of the Society is directed through sub-committees: The Accreditation Committee, responsible for personal accreditation; the Clinical Standards Committee, responsible for departmental accreditation and the Leadership Academy; the Education Committee, responsible for scientific meetings, guidelines, on-line learning and research; the Communication Committee, responsible for publications, clinical content on the website and membership engagement. There is also a standing committee comprising the Honorary Officers Committee chairs and CEO, with monthly communication by videoconference.

7

British Society of Echocardiography Trustees’ Annual Report for the Year Ended 31 March 2021

The Board and its committees are supported by the office team. The committees, CEO and administrative staff have delegated authority to carry out day to day work within policies approved by the Board.

Significant Changes, Developments and Plans for the Future

The Society has invested in establishing an adequate infrastructure to meet the needs of its members and is now financially stable. The Society has proved to be resourceful and adaptable. Its relatively small scale has facilitated quick decision making and its robust processes have ensured our sustainability for our members and the benefit of the public.

Looking to the future, we will be completing our Governance review, to ensure we meet Charity Commission guidance and to protect our members’ interests. We are launching a new Workforce strategy, with an initial survey to accurately identify the current situation both in terms of resource and demand. Once we have data, we can assess the problems, identify regional and national trends and act appropriately. This will be a long-term strategy for the Society. We acknowledge the workforce crisis is widespread and there will be no easy fixes. However, once we can evidence and articulate the problems clearly, we can start to work with relevant bodies to deal with them.

We will relaunch ERP, with a renewed emphasis on achieving an impact factor. Initially we will support member contributions of original research through sponsored APCs. The Journal is seen as a pivotal vehicle for publicising BSE guidelines and for raising our profile globally.

From an education perspective, we will look to return to face-to-face events, with a digital offering alongside. Whilst we know many of our members are looking forward to being able to come back together to learn in person again, we are also aware that virtual education offerings have opened up our valuable resources to many more people. Ensuring our education remains accessible will be a continuing priority and so offering hybrid events for our key conferences, such as BSEcho and BSE and ICE.

Method of Election of the Trustees

As described in the Company's current Articles of Association, not more than 15 individuals shall be appointed as Members of Council, for a term of up to 3 years; and all are eligible for re-election of a further 3-year term. 12 Council members shall be elected by the Company members and 3 shall be co-opted by Council.

If the President and/or the President-Elect is a medically qualified doctor (including but not limited to a cardiologist), only a person who practises another discipline from the range of disciplines practised by the Members shall be eligible to be nominated and appointed as either Vice President or Vice President-Elect and vice versa.

Any vacancies on Council will be advised to Company members at least 6 weeks and nominations from members must be received at least 4 weeks before the AGM. If nominations exceed the number of vacancies a ballot will be held, and each Company member will have 1 vote for each Council vacancy. After the AGM, the Council will co-opt 3 Council members and appoint the Officers. Council may appoint at any time to fill a vacancy for the period up to the following AGM.

Trustees’ training was reviewed and a Trustee Induction Programme introduced to ensure a thorough understanding of responsibilities and all areas of good governance.

The Articles are currently being reviewed as part of the Governance review.

8

British Society of Echocardiography Trustees’ Annual Report for the Year Ended 31 March 2021

Remuneration policy

All newly recruited staff are subject to the Society’s probationary period which includes KPIs that are reviewed before employment is confirmed. The Society conducts an annual appraisal and pay review for all staff, measuring staff performance against KPIs with due regard to industry benchmarks and salary levels for similar roles.

Review of the Society’s Financial Position

The financial accounts are set out on pages 14 to 28 together with notes to the accounts. The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) - (Charities SORP FRS 102), The Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (March 2018) and the Companies Act 2006.

The Statement of Financial Activities show net incoming resources for the year of £97k before accounting for investment gains of £48k giving net income for the year of £145k (2020: net outgoing of £67k). The total unrestricted funds at the year end, stand at £569k (2020: £424k). Most of the Society’s usual expenditure is spent on management and administration of core activities.

The Society’s investment portfolio is managed by Chase De Vere and is restricted to ethical investments. During the year, the portfolio grew by £48k after capital withdrawals of £100k total.

Despite the continuing uncertainty in the economy, we do not foresee any factors which are likely to affect our future financial position.

Availability and adequacy of assets of each of the funds

The board of Trustees is satisfied that the charity's assets are available and adequate to fulfil its obligations.

A budgeted deficit of £55k was set for the year with expectations of a financially difficult period. As a result of quickly adapting to the circumstances, the Society has returned a surplus of £97k excluding investment gains. The surplus can now be directed to supporting membership benefits.

The Trustees consider the Society remains a going concern.

Policies on reserves

The Reserves Policy states the Society maintains free unrestricted reserves to provide a level of working capital that protects the continuity of our core work; to maintain a minimum reserve level equivalent to four - six months of general expenditure; to provide a level of funding for unexpected opportunities; to provide cover for risks such as unforeseen expenditure or unanticipated loss of income. The Trustees will continue to review the above criteria with reference to the Charity’s strategy and Annual Plan and determine the target level of free reserves to meet these.

The total funds held on 31[st] March 2021 were £572k, of which £4k is restricted. After accounting for fixed assets of £55k, the unrestricted free reserves of the Charity are £514k. The Trustees are satisfied that this level of reserves is adequate, as it represents approximately 7 months of general expenditure which is consistent with the minimum reserve level of 4-6 months as set in the policy.

9

British Society of Echocardiography Trustees’ Annual Report for the Year Ended 31 March 2021

The restricted funds are donations towards the Echo in Africa programme and were transferred to the programme in April 2021.

Major risks to which the charity is exposed and reviews and systems to mitigate risks

The Trustees monitor risks to the charity each financial year when preparing and updating a strategic plan, in particular those related to the operation and finance of the charity. The Trustees then establish systems to mitigate those risks.

The Society’s Risk Register identifies a number of high, medium, and low risks (both strategic and operational) currently facing the Society. The Risk Register, which is reviewed by the Trustees at meetings throughout the year, identifies actions required to improve systems and controls in order to mitigate exposure to the risks which have been so identified and reviewed. These include the requirement for detailed financial reports to be presented to the Trustees on a quarterly basis and for the accounts to be regularly explained to all members of the charity and open for member's inspection at any time.

The Society had previously identified that it needed to strengthen its governance and has been going through a process to ensure robust processes are in place and that roles and responsibilities are clearly defined. We no longer view governance as a high risk.

In the current environment we anticipate cyber threats, for instance a data breach or ransomware attack, to be viewed as higher risks. We employ a dedicated IT consultant to advise us on security of both systems and software and invest in appropriate levels of security.

We have an experienced and highly valued team of staff and are alert to the risk of losing vital knowledge and skills. We offer development opportunities, benchmark salaries and regularly review packages to retain our team.

Public benefit

The Trustees have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the charity's aims and objectives and in planning its future activities. In particular, the Trustees consider how planned activities will contribute to the aims and objectives that have been set.

As an organisation working in the field of healthcare, the raison d’etre of the BSE is to protect and preserve health, and to relieve sickness through improvement in echocardiography. Specific areas in which it seeks to achieve this include:

(a) Promoting the highest professional standards in clinical echocardiography through personal and departmental accreditation, revalidation, and enforcement of a code of professional conduct. (b) Providing and facilitating training through education and development.

(c) Education through publications, guidelines, and on-line learning

(d) Working with government bodies and organisations to develop a career structure for sonographers that attracts and retains high-calibre staff in diagnostic centres, to promote the profession as an important resource, and to build the profession to meet increasing demand in hospitals, the community and private sector.

The Trustees would like to acknowledge the significant contribution made by all who volunteer their time to support the work of the Society.

10

British Society of Echocardiography Trustees’ Annual Report for the Year Ended 31 March 2021

British Society of Echocardiography

The members of the Board of Trustees of the Charity and Directors of the Company at the date the report and accounts were approved: -

Dr D Augustine Mr K Pearce Ms S Bennett Dr S Robinson Dr C Colebourn Ms J Skipper Ms W Gamlin Prof M Stout Dr S Mushemi-Blake Ms K Victor Ms C Oxley

The following served as Trustees and Directors during the year:

Dr A Macnab (resigned October 2020) Ms S Baker (resigned October 2020)

Secretary Ms J Skipper

Statement of responsibilities of the trustees

The trustees (who are also directors of the charitable company for the purposes of company law) are responsible for preparing the trustees’ annual report (which incorporates the company directors’ report) and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company Law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing those financial statements the trustees are required to:

The trustees are also responsible for maintaining proper accounting records which disclose with reasonable accuracy at any time the financial position of the charity and which are sufficient to show and explain the charity's transaction and enable them to ensure that statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

11

British Society of Echocardiography Trustees’ Annual Report for the Year Ended 31 March 2021

Members of the charity guarantee to contribute an amount not exceeding £10 to the assets of the charity in the event of winding up. The total number of such guarantees at 31st March 2021 was 4,158 (2020: 4,260). The trustees are members of the charity, but this entitles them only to voting rights. The trustees have no beneficial interest in the charity.

No trustee received any remuneration for these services; expenses reimbursed are shown in note 9 to the financial statements.

This report has been prepared in accordance with the provision in Part 15 of the Companies Act 2006 applicable to companies subject to the small companies’ regime.

This report was approved by the Board of Trustees on the 10[th] September 2021

...............................................

Dr Claire Colebourn

Director and Trustee

12

Independent examiner’s report

To the trustees of British Society of Echocardiography

I report to the charity trustees on my examination of the accounts of the charity for the year ended 31 March 2021.

This report is made solely to the trustees as a body, in accordance with the Charities Act 2011. My examination has been undertaken so that I might state to the trustees those matters I am required to state to them in an independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the charity and the trustees as a body, for my examination, for this report, or for the opinions I have formed.

Responsibilities and basis of report

As the trustees of the charity (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charity’s accounts carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner’s statement

Since the charitable company’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants of England and Wales (the ICAEW) which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Caroline Sharp FCA, DChA London SE7

Date: 4 October 2021

13

British Society of Echocardiography

Statement of financial activities (incorporating an income and expenditure account)

For the year ended 31 March 2021

Note
Income from:
2
Membership
3
4
5
6
Membership
7
7
7
7
Education: Research and training
7
23
15
9
Reconciliation of funds:
Charitable activities
Donations
Annual conference and meetings
Accreditation
Total expenditure
Charitable activities
Annual conference and meetings
Accreditation
Echo in Africa
Bank interest
Total income
Expenditure on:
Other income
Echo in Africa
Misappropriated funds
Total funds carried forward
Net movement in funds
Total funds brought forward
Net gains on investments
Net income/(expenditure) for the year
Net income/(expenditure) before net gains
on investments
Unrestricted
£
-
398,162
299,681
163,570
-
613
8
Restricted
£
17,130
-
-
-
-
-
-
2021
Total
£
17,130
398,162
299,681
163,570
-
613
8
879,164
257,894
279,951
212,545
-
31,389
-
781,779
47,596
144,981
144,981
427,467
572,448
97,385
Unrestricted
£
-
318,563
380,301
209,531
-
1,358
26
Restricted
£
-
-
-
-
13,250
-
-
2020
Total
£
-
318,563
380,301
209,531
13,250
1,358
26
862,034 17,130 909,779 13,250 923,029
257,894
279,951
212,545
-
14,259
-
-
-
-
17,130
-
248,896
412,807
296,642
-
8,816
14,663
-
-
-
11,007
-
-
248,896
412,807
296,642
11,007
8,816
14,663
764,649 17,130 981,824 11,007 992,831
47,596
97,385
-
-
2,949
(72,045)
-
2,243
2,949
(69,802)
144,981
144,981
423,759
-
-
3,708
(69,096)
(69,096)
492,855
2,243
2,243
1,465
(66,853)
(66,853)
494,320
568,740 3,708 423,759 3,708 427,467

All of the above results are derived from continuing activities. There were no other recognised gains or losses other than those stated above. Movements in funds are disclosed in Note 21a to the financial statements.

14

British Society of Echocardiography

Balance sheet

Company no. 04480121

As at 31 March 2021

Note
£
Fixed assets:
14
15
Current assets:
16
146,773
350,476
497,249
Liabilities:
17
199,360
20a
21a
Total charity funds
Investments
Cash at bank and in hand
Tangible assets
The funds of the charity:
Creditors: amounts falling due within one year
Net current assets
Total net assets
Debtors
Restricted income funds
Unrestricted general funds
2021
£
55,078
219,481
£
162,401
119,406
2020
£
51,527
271,885
274,559
297,889
323,412
104,055
281,807
177,752
572,448 427,467
3,708
568,740
3,708
423,759
572,448 427,467

For the year ending 31 March 2021 the charitable company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies’ regime

Approved by the trustees on 10 September 2021 and signed on their behalf by

Dr Sitali Mushemi-Blake

Treasurer

15

British Society of Echocardiography

Statement of cash flows

For the year ended 31 March 2021

Note
Cash flows from operating activities
Net income/(expenditure) for the reporting period
(as per the statement of financial activities)
Depreciation charges
(Gains)/losses on investments
(Increase)/decrease in debtors
Increase/(decrease) in creditors
Net cash from/(used in) operating activities
a
Analysis of cash and cash equivalents and of net debt
Cash at bank and in hand
a
Total cash and cash equivalents
Cash and cash equivalents at the beginning of the
year
Net cash provided by investing activities
Cash flows from investing activities:
Purchase of fixed assets
Proceeds from sale of investments
Cash and cash equivalents at the end of the year
Change in cash and cash equivalents in the year
£
£
144,981
15,201
(47,596)
15,628
21,608
149,822
(18,752)
100,000
81,248
231,070
119,406
350,476
At 1 April
2020
Cash flows
£
£
119,406
231,070
119,406
231,070
2021
£
£
144,981
15,201
(47,596)
15,628
21,608
149,822
(18,752)
100,000
81,248
231,070
119,406
350,476
At 1 April
2020
Cash flows
£
£
119,406
231,070
119,406
231,070
2021
£
£
(66,853)
5,725
(2,949)
(38,005)
(12,160)
(114,242)
(57,252)
99,996
42,744
(71,498)
190,904
119,406
Other non-
cash
changes
At 31
March
2021
£
£
-
350,476
-
350,476
2020
£
£
(66,853)
5,725
(2,949)
(38,005)
(12,160)
(114,242)
(57,252)
99,996
42,744
(71,498)
190,904
119,406
Other non-
cash
changes
At 31
March
2021
£
£
-
350,476
-
350,476
2020
149,822
81,248
(114,242)
42,744
At 1 April
2020
£
119,406
Other non-
cash
changes
£
-
231,070
119,406
(71,498)
190,904
350,476 119,406
Cash flows
£
231,070
At 31
March
2021
£
350,476
119,406 231,070 - 350,476

16

British Society of Echocardiography

Notes to the financial statements

For the year ended 31 March 2021

1 Accounting policies

a) Statutory information

British Society for Echocardiography is charitable company limited by guarantee and is incorporated in England. The registered office and operational address is Unit 204, The Print Rooms, 164-180 Union Street, London, England, SE1 0LH.

b) Basis of preparation

The accounts (financial statements) have been prepared in accordance with the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP FRS 102), the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) (March 2018) and the Companies Act 2006.

Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy or note.

In applying the financial reporting framework, the trustees have made a number of subjective judgements, for example in respect of significant accounting estimates. Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The nature of the estimation means the actual outcomes could differ from those estimates. Any significant estimates and judgements affecting these financial statements are detailed within the relevant accounting policy below.

c) Public benefit entity

The charity meets the definition of a public benefit entity under FRS 102.

d) Going concern

The trustees consider that there are no material uncertainties about the charity's ability to continue as a going concern.

The Trustees are mindful of the Covid-19 pandemic and its potential impact on the BSE’s operations; the main risks identified that could impact future income are the inability to run face to face events, such as Annual Conference and that Members will have less disposable income because of Covid-19. Having identified these risks at an early stage measures are being taken to mitigate the risks, including a swift move to virtual events ensuring continued service delivery and income generation, minimisation of cancellation costs wherever possible and a period of grace for members who were struggling to pay fees, protecting our membership for the longer term. Whilst the pandemic has had an impact on the organisation’s income, it is the Trustees’ strong view that we have the plans, controls and reserves in place to ensure the BSE is a going concern.

The trustees do not consider that there are any other sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next reporting period.

e) Income

Income is recognised when the charity has entitlement to the funds, any performance conditions attached to the income have been met, it is probable that the income will be received and that the amount can be measured reliably.

Income from government and other grants, whether ‘capital’ grants or ‘revenue’ grants, is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred.

The membership year runs concurrently with the financial year. Membership subscriptions received in the first 9 months of the accounting period are considered to relate to that membership year. Subscriptions received from January to March relate to the next membership period and are accounted for as deferred income.

Income received in advance of the provision of a specified service is deferred until the criteria for income recognition are met.

17

British Society of Echocardiography

Notes to the financial statements

For the year ended 31 March 2021

g) Fund accounting

Restricted funds are to be used for specific purposes as laid down by the donor. Expenditure which meets these criteria is charged to the fund.

Unrestricted funds are donations and other incoming resources received or generated for the charitable purposes.

Designated funds are unrestricted funds earmarked by the trustees for particular purposes.

h) Expenditure and irrecoverable VAT

Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably. Expenditure includes attributable VAT, which cannot be recovered.

i) Grants payable

Grants payable are made to third parties in furtherance of the charity's objects. Single or multi-year grants are accounted for when either the recipient has a reasonable expectation that they will receive a grant and the trustees have agreed to pay the grant without condition, or the recipient has a reasonable expectation that they will receive a grant and that any condition attaching to the grant is outside of the control of the charity.

Resources expended are allocated to the particular activity where the cost relates directly to that activity. However, the cost of overall direction and administration of each activity, comprising the salary and overhead costs of the central function, is apportioned on the following basis which are an estimate, based on staff time, of the amount attributable to each activity.

Where information about the aims, objectives and projects of the charity is provided to potential beneficiaries, the costs associated with this publicity are allocated to charitable expenditure.

2021 2020
Membership services 45% 35%
Annual conference and meetings 35% 41%
Accreditation 19% 23%
Education: Research and training 1% 1%

Governance costs are the costs associated with the governance arrangements of the charity. These costs are associated with constitutional and statutory requirements and include any costs associated with the strategic management of the charity’s activities.

18

British Society of Echocardiography

Notes to the financial statements

For the year ended 31 March 2021

1 Accounting policies (continued)

l) Operating leases

Rental charges are charged on a straight line basis over the term of the lease.

m) Tangible fixed assets

Items of equipment are capitalised where the purchase price exceeds £1,000. Depreciation costs are allocated to activities on the basis of the use of the related assets in those activities. Assets are reviewed for impairment if circumstances indicate their carrying value may exceed their net realisable value and value in use. Major components are treated as a separate asset where they have significantly different patterns of consumption of economic benefits and are depreciated separately over its useful life.

Where fixed assets have been revalued, any excess between the revalued amount and the historic cost of the asset will be shown as a revaluation reserve in the balance sheet.

Depreciation is provided at rates calculated to write down the cost of each asset to its estimated residual value over its expected useful life. The depreciation rates in use are as follows:

k) Listed investments

Investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing

quoted market price. Any change in fair value will be recognised in the statement of financial activities. Investment gains and losses, whether realised or unrealised, are combined and shown in the heading “Net gains/(losses) on investments” in the statement of financial activities. The charity does not acquire put options, derivatives or other complex financial instruments.

l) Debtors

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

m) Cash at bank and in hand

Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

n) Creditors and provisions

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

1 Accounting policies (continued)

o) Financial instruments

With the exception of the listed investments described above the charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

Non-basic financial instruments (investments) are measured at fair value with any gain or loss going to the statement of financial activities.

p) Pensions

The charity participates in a defined contribution pension scheme with Welplan pensions which is available to all employees. The pension cost charge represents contributions payable under the scheme by the charity to the fund. The charity has no liability under the scheme other than for the payment of those contributions.

19

British Society of Echocardiography

Notes to the financial statements

For the year ended 31 March 2021

2 Donations

2
Donations
2021
Restricted
Total
£
£
17,130
17,130
3
2021
Unrestricted
Total
£
£
Members' annual subscriptions
380,204
380,204
NHS England for poster sets
10,198
10,198
Publications - newsletter and website advertising
7,760
7,760
Total
398,162
398,162
4
2021
Unrestricted
Total
£
£
Registration fees
193,763
193,763
Exhibitors fees
18,750
18,750
Sponsorship
25,995
25,995
Training days
61,173
61,173
Total
299,681
299,681
2021
5
Accreditation
Unrestricted
Total
£
£
Accreditation fees
163,570
163,570
Event endorsement
-
-
Other accreditation income
-
-
Total accreditation
163,570
163,570
861,413
861,413
6
2021
Total
£
£
-
-
British Heart Foundation Grant
Echo in Africa
Total income from charitable activities
Annual conference and meetings
Membership services
All income from membership services (2020 and 2019) is unrestricted.
All conference and meeting income (2020 and 2019) is unrestricted.
Other donations
All accreditation income (2020 and 2019) is unrestricted.
Restricted
Restricted
£
17,130
2021
Total
£
17,130
£
-
Restricted
2020
Total
£
-
Unrestricted
£
380,204
10,198
7,760
2021
Total
£
380,204
10,198
7,760
£
302,540
-
16,023
Unrestricted
2020
Total
£
302,540
-
16,023
398,162 398,162 318,563 318,563
£
252,951
58,925
36,705
31,720
Unrestricted
2020
Total
£
252,951
58,925
36,705
31,720
299,681 299,681 380,301 380,301
£
206,513
1,530
1,488
Unrestricted
2020
Total
£
206,513
1,530
1,488
163,570 163,570 209,531 209,531
861,413 861,413 908,395 908,395
2021
Total
£
-
£
13,250
Restricted
2020
Total
£
13,250

All income for Echo in Africa is restricted. Other donations include donations from volunteers participating in the programme.

20

British Society of Echocardiography

Notes to the financial statements

For the year ended 31 March 2021

Charitable activities

Staff costs (Note 10)
Recruitment and other staff costs
Consultancy fees
Training days
Room hire and facilities
Travel and subsistence
Postage and communication
Administration and secretarial
Examination facilities
Examiners fees and expenses
Grants and awards (Note 8)
Council travel and meeting expenses
BCS meeting expenses
Printing, stationery and publishing
Website and IT
Office rent and rates
Office maintenance
Equipment
Insurance
Legal and professional
Accountancy and independent examination
Meeting facilities
Depreciation
Bank and merchant charges
Irrecoverable VAT
Sundry
Support costs
Governance costs
Total expenditure 2021
£
-
-
-
-
-
-
445
1,048
-
-
-
-
-
74,840
-
-
-
-
-
-
-
-
-
-
-
-
Membership
services
£
-
-
-
-
134,526
225
-
-
-
-
-
-
-
2,641
-
-
-
-
-
-
-
-
-
-
-
1,345
Annual
conference
and meetings
£
72,610
-
-
-
-
3,378
1,286
14
54,991
1,526
-
-
-
638
-
-
-
62
-
796
-
-
-
569
-
15
Accreditation
Echo in
Africa
£
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education:
Research
and training
£
-
-
-
10,209
-
15
-
-
-
-
17,130
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Governance
costs
£
-
-
-
-
-
-
-
-
-
-
-
61
-
-
-
-
-
-
-
-
1,300
-
-
-
-
-
Support
costs
£
241,848
8,898
6,607
-
-
92
4,613
321
-
-
-
-
-
99
40,962
26,285
8,043
4,165
1,757
9,143
1,382
-
15,201
9,194
19,698
3,801
2021 Total
£
314,458
8,898
6,607
10,209
134,526
3,710
6,344
1,383
54,991
1,526
17,130
61
-
78,218
40,962
26,285
8,043
4,227
1,757
9,939
2,682
-
15,201
9,763
19,698
5,161
2020 Total
£
262,978
8,450
23,375
26,062
194,230
56,850
9,405
31,863
77,462
3,429
8,485
10,124
3,353
110,515
16,022
9,078
7,235
5,966
6,169
16,289
4,237
1,146
5,725
10,567
63,307
5,845
76,333
180,949
612
138,737
140,738
476
135,885
76,401
259
-
-
-
27,354
4,021
14
1,361
-
(1,361)
402,109
(402,109)
-
781,779
-
-
978,167
-
-
257,894 279,951 212,545 - 31,389 - - 781,779 978,167

21

British Society of Echocardiography

Notes to the financial statements

For the year ended 31 March 2021

£
Staff costs (Note 10)
-
Recruitment and other staff costs
-
Consultancy fees
-
Training days
-
Room hire and facilities
-
Travel and subsistence
-
Postage and communication
2,690
Administration and secretarial
-
Examination facilities
-
Examiners fees and expenses
-
Grants and awards
-
Council travel and meeting expenses
-
BCS meeting expenses
-
Printing, stationery and publishing
98,616
Website and IT
-
Office rent and rates
-
Office maintenance
-
Equipment
-
Insurance
-
Legal and professional
-
Accountancy and independent examin
-
Meeting facilities
-
Depreciation
-
Bank and merchant charges
-
Irrecoverable VAT
-
Sundry
-
101,306
Support costs
142,960
Governance costs
4,630
Total expenditure 2020
248,896
Membership
services
Charitable activities Charitable activities Governance
costs
£
-
-
-
-
-
-
-
-
-
-
-
10,124
3,104
-
-
-
-
-
-
-
-
-
-
-
-
-
Support
costs
£
194,985
4,275
23,375
26,062
-
10,863
5,355
-
-
-
-
-
-
2,121
11,483
9,078
7,235
5,966
3,744
15,054
4,237
-
5,725
9,747
63,307
5,845
2020 Total
£
262,978
8,450
23,375
26,062
194,230
56,850
9,405
31,863
77,462
3,429
8,485
10,124
3,353
110,515
16,022
9,078
7,235
5,966
6,169
16,289
4,237
1,146
5,725
10,567
63,307
5,845
£
-
-
-
-
194,230
8,079
-
31,719
-
-
629
-
-
5,260
-
-
-
-
-
-
-
-
-
-
-
-
Annual
conference
and meetings
£
67,993
4,175
-
-
-
33,752
1,360
144
77,462
3,429
-
-
249
4,518
4,539
-
-
-
-
1,235
-
-
-
798
-
-
Accreditation
Echo in
Africa
£
-
-
-
-
-
704
-
-
-
-
7,856
-
-
-
-
-
-
-
2,425
-
-
-
-
22
-
-
Education:
Research
and training
£
-
-
-
-
-
3,452
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1,146
-
-
-
-
101,306
142,960
4,630
239,917
167,467
5,423
199,655
93,945
3,042
11,007
-
-
4,598
4,085
133
13,228
-
(13,228)
408,457
(408,457)
-
978,167
-
248,896 412,807 296,642 11,007 8,816 - - 978,167

22

British Society of Echocardiography

Notes to the financial statements

For the year ended 31 March 2021

Grant making
Educational bursaries
Echo in Africa donation
Travel bursaries
At the end of the year
Cost
Grants to
institutions
£
-
-
-
Grants to
individuals
£
-
17,130
-
2021
£
-
17,130
-
Grants to
institution
7,856
-
-
Grants to
individuals
£
-
-
629
2020
£
7,856
-
629
- 17,130 17,130 7,856 - 8,485

Echo in Africa - payments are made under a programme funded by a grant from Edwards Life Sciences to Sunheart as a contribution towards the costs of a PhD student and other costs associated with the volunteer programme in South Africa. Further information about the programme and movements in funds is shown in note 21.

Educational bursaries were made of £100 to 54 individuals to enable them to attend the Annual Conference, and 782 bursaries of £15 to individuals to cover the cost of attending an online learning module. The bursaries were funded by the British Heart Foundation grant (see note 2 and 21a)

Travel bursaries are paid to individuals to enable them to attend the Annual Conference or other events to benefit their learning and skills development. No bursaries were made during 2020/21.

9 Net income for the year

This is stated after charging / (crediting):

This is stated after charging / (crediting):
2021 2020
£ £
Depreciation 15,201 5,725
Operating lease rentals payable:
Property 23,592 25,549
Other 6,823 6,823
Independent examiner's remuneration (excluding VAT):
Independent examiner fee - current year 1,300 2,100
Independent examiner fee - over accrued in prior year (800) -
Other services (*) 882 2,137

(*) Other fees paid to independent examiner relate to assistance with accounting for VAT, and investigation of misappropriated funds. Fees paid for examination include preparation of statutory accounts.

23

British Society of Echocardiography

Notes to the financial statements

For the year ended 31 March 2021

10 Analysis of staff costs, trustee remuneration and expenses, and the cost of key management personnel

Staff costs were as follows:

Staff costs were as follows:
Salaries and wages
Temporary and casual staff wages
Social security costs
Employer’s contribution to defined contribution pension schemes
2021
£
219,788
56,032
19,663
18,975
2020
£
178,309
56,421
16,143
12,105
314,458 262,978

One employee earned between £70,000 - £79,999 during the year (2020: One £60,000 - £69,999).

The total employee benefits (including pension contributions and employer's national insurance) of the key management personnel was £85,602 (2020: £75,929).

The charity trustees were neither paid nor received any other benefits from employment with the charity in the year (2020: £nil). No trustee received payment for professional or other services supplied to the charity (2020: Nil).

Trustees' expenses represents the payment or reimbursement of travel and subsistence costs totalling £361.78 (2020: £5,143.32) incurred by 6 (2020: 10) trustees relating to attendance at meetings of the Council of trustees and other BSE meetings and events. However, due to the pandemic, the majority of our meetings and events were carried out on a virtual basis. The expenses detailed were incurred during the AGM in October. We were not required to refund any Trustees Annual Conference registration fees for speaking at the Conference, as per previous years (2020 : £1,045.35).

11 Staff numbers

The average number of employees (head count based on number of staff employed) during the year was 5.2 (2020: 4.3).

Staff are split across the activities of the charity as follows (head count basis):

Staff are split across the activities of the charity as follows (head count basis):
Annual conference and meetings
Accreditation
Membership services and support
Additional full-time support provided by temporary staff
2021
No.
2.0
1.0
2.2
2020
No.
1.8
-
2.5
5.2 4.3
1 1

12 Related party transactions

There are no related party transactions to disclose for 2021 (2020: none).

There are no donations from related parties which are outside the normal course of business and no restricted donations from related parties.

13 Taxation

The charity is exempt from corporation tax as all its income is charitable and is applied for charitable purposes.

24

British Society of Echocardiography

Notes to the financial statements

For the year ended 31 March 2021

14 Tangible fixed assets

Equipment
Website
£
£
49,530
57,252
-
18,752
49,530
76,004
49,530
5,725
-
15,201
49,530
20,926
-
55,078
-
51,527
15
2021
£
271,885
(100,000)
47,596
219,481
2021
£
219,449
32
219,481
16
2021
£
57,303
9,198
80,272
146,773
Trade debtors
Other debtors
Prepayments and accrued income
Debtors
Net gain on change in fair value
Cash
Disposal proceeds
Fair value at the end of the year
UK Common investment funds
Investments comprise:
Annual Investment managers fees and charges of c. £4k are included in the net change in fair value.
Depreciation
At the end of the year
Net book value
Charge for the year
At the end of the year
Listed investments
At the start of the year
Additions in year
Cost
At the start of the year
At the end of the year
At the start of the year
All of the above assets are used for charitable purposes.
Fair value at the start of the year
Equipment
£
49,530
-
Website
£
57,252
18,752
Total
£
106,782
18,752
49,530 76,004 125,534
49,530
-
5,725
15,201
55,255
15,201
49,530 20,926 70,456
- 55,078 55,078
- 51,527 51,527
2021
£
271,885
(100,000)
47,596
2020
£
368,932
(99,996)
2,949
219,481 271,885
2020
£
271,687
198
219,481 271,885
2021
£
57,303
9,198
80,272
2020
£
26,585
26,872
108,944
146,773 162,401

25

British Society of Echocardiography

Notes to the financial statements

For the year ended 31 March 2021

17 Creditors: amounts falling due within one year

Creditors: amounts falling due within one year
Accruals
Deferred income (note 18)
Trade creditors
Taxation and social security
Other creditors
2021
£
42,198
9,791
5,028
19,178
123,165
2020
£
59,273
7,186
5,314
28,894
77,085
199,360 177,752

18 Deferred income

Deferred income comprises sponsorship and member subscriptions received in advance.

Balance at the beginning of the year
Amount released to income in the year
Amount deferred in the year
Balance at the end of the year
2021
£
77,085
(77,085)
123,165
2020
£
56,420
(56,420)
77,085
123,165 77,085

19 Financial instruments

Financial instruments
Financial assets measured at fair value through profit and loss
Investments
Tangible fixed assets
Analysis of net assets between funds (current year)
Investments
Net current assets
Net assets at 31 March 2021
Analysis of net assets between funds (prior year)
Net assets at 31 March 2020
Tangible fixed assets
Investments
Net current assets
General
unrestricted
£
55,078
219,481
294,181
2021
£
219,481
2020
£
271,885
Restricted
£
-
-
3,708
Total funds
£
55,078
219,481
297,889
568,740 3,708 572,448
General
unrestricted
£
51,527
271,885
100,347
Restricted
£
-
-
3,708
Total funds
£
51,527
271,885
104,055
423,759 3,708 427,467

20a Analysis of net assets between funds (current year)

20b Analysis of net assets between funds (prior year)

26

British Society of Echocardiography

Notes to the financial statements

For the year ended 31 March 2021

21a Movements in funds (current year)

Total restricted funds
General funds
Restricted funds:
Echo in Africa
British Heart Foundation
Total unrestricted funds
Total funds
At 1 April
2020
£
-
3,708
Income &
gains
£
17,130
-
Expenditure
& losses
£
(17,130)
-
Transfers
£
-
-
£
-
3,708
At 31 March
2021
3,708 17,130 (17,130) - 3,708
423,759 909,630 (764,649) - 568,740
423,759 909,630 (764,649) - 568,740
427,467 926,760 (781,779) - 572,448

Purposes of restricted funds

British Heart Foundation - Alliance Transitional funding to provide bursaries to enable BSE members to attend BSEcho 2020, and for publication of pulmonary hypertension eLearning module for 4,000 members.

Echo in Africa - was a collaborative project between the Society and SUNheart in South Africa. Funding is provided by a grant from Edwards Lifesciences Foundation under their Every Heartbeat Matters programme, and other donations. As the Echo in Africa 6 year program has now come to an end, the Trustees are considering where it can best apply its efforts in terms of humanitarian projects in the future.

21b Movements in funds (prior year)

Total restricted funds
General funds
Total funds
Total unrestricted funds
Restricted funds:
Echo in Africa
At 2 April
2019
£
1,465
Income &
gains
£
13,250
Expenditure
& losses
£
(11,007)
Transfers
£
-
At 31
March 2020
£
3,708
1,465 13,250 (11,007) - 3,708
492,855 912,728 (981,824) - 423,759
492,855 912,728 (981,824) - 423,759
494,320 925,978 (992,831) - 427,467

22 Operating lease commitments payable as a lessee

The charity's total future minimum lease payments under non-cancellable operating leases is as follows for each of the following periods

each of the following periods
Less than one year
One to five years
Over five years
2021
2020
£
£
9,198
13,359
-
-
-
-
9,198
13,359
Property
2021
2020
£
£
6,322
6,572
1,518
7,840
-
-
7,840
14,412
Equipment
9,198 13,359 7,840 14,412

27

British Society of Echocardiography

Notes to the financial statements

y [ , ] ( [

,

]) p [ ]

23 Misappropriated funds

The British Society of Echocardiography (BSE) were alerted to suspicious activity on their bank account by NatWest bank in May 2019 and initiated a review of transactions. It later transpired that funds had been misappropriated. Communication of the incident has been made to members, Council members and the Charity Commission. The police have also been informed and a criminal investigation is in progress.

BSE engaged a firm of independent accountants to investigate and quantify the level of misappropriated funds. The results of this investigation indicated the following:

Total unauthorised and unverified transfers out of bank accounts
Less: Total unauthorised and unverified transfers in to bank
Net estimated funds misappropriated
Financial year ending 31 March:
2020
16,429
(1,765)
2019
187,791
(27,486)
2018
34,159
-
14,664 160,305 34,159

The transactions were hidden in the accounting records by not recording income relating to membership matching the transfers out. The Sage accounts for 2018/2019 were updated to record the total income received from members and the net funds transferred out as expenditure. In 2019/20 funds were transferred from the BSE bank accounts without the Trustees’ authority and not for the Society’s use.

Costs of the investigation in professional fees (note 6a)

8,750 - -

24 Contingent assets and liabilities

Further to the issue discussed above the charity is hopeful that some costs may be recovered, but as there is a significant element of uncertainty of the timing and amount that can be expected, no provision has been made for any repayments that may be received. The Trustees continue to work with the authorities to ensure that this is brought to a satisfactory conclusion, including the recovery of funds.

It is not anticipated that further costs will be incurred on this matter, however it is felt prudent to have a contingency provision available in order to ensure the Trustees can take every action necessary to recover what was lost.

25 Legal status of the charity

The charity is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up is limited to £10.

28